Wyeth responds to news story on oral contraceptives and DVT.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 1120638)

Published in BMJ on June 30, 2001

Authors

P Brock

Articles cited by this

Wyeth suppresses research on pill, programme claims. BMJ (2001) 1.56

Articles by these authors

Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem (1983) 3.91

Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J Clin Microbiol (1999) 2.20

Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2. Eur J Cancer (2004) 1.60

Light-directed synthesis of high-density oligonucleotide arrays using semiconductor photoresists. Proc Natl Acad Sci U S A (1996) 1.48

Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer (2000) 1.47

Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol (2000) 1.44

Ethics and pharmaceutical medicine -- the full report of the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK. Int J Clin Pract (2006) 1.34

Guiding Principles for Pharmaceutical Physicians from the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK. Int J Clin Pract (2006) 1.25

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia (2000) 1.25

Cutaneous involvement in children with acute lymphoblastic leukemia or lymphoblastic lymphoma. The Children's Leukemia Cooperative Group of the European Organization of Research and Treatment of Cancer (EORTC). Pediatrics (1997) 1.19

Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer (1998) 1.19

Reducing sleep disruptions in young children: evaluation of therapist-guided and written information approaches: a brief report. J Child Psychol Psychiatry (1989) 1.16

Reversible hypophosphatemic rickets following ifosfamide treatment. Med Pediatr Oncol (1992) 1.13

Sudden blindness in a child: presenting symptom of a sphenoid sinus mucocele. Br J Ophthalmol (1992) 1.10

Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience. Eur J Cancer (2013) 1.08

Infantile fibrosarcoma. Med Pediatr Oncol (1991) 1.07

Case series: 2q33.1 microdeletion syndrome--further delineation of the phenotype. J Med Genet (2011) 1.05

Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trial. Eur J Cancer (2012) 0.99

Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study. Eur J Cancer (2013) 0.95

Ototoxicity of cisplatinum. Br J Cancer (1991) 0.95

Pleuropulmonary blastoma (pulmonary blastoma of childhood): genetic link with other embryonal malignancies? Histopathology (1994) 0.92

Clinical and molecular characterization of individuals with recurrent genomic disorder at 10q22.3q23.2. Clin Genet (2010) 0.92

Consecutive glioblastoma and B cell non-Hodgkin's lymphoma in a young child with von Recklinghausen's Neurofibromatosis. Med Pediatr Oncol (1995) 0.89

Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors. Cancer (2000) 0.89

Structure and optical properties of several organic-inorganic hybrids containing corner-sharing chains of bismuth iodide octahedra. Inorg Chem (2001) 0.86

Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridisation analysis. Eur J Cancer (1997) 0.85

Cytogenetic and immunohistochemical evidence that giant cell fibroblastoma is related to dermatofibrosarcoma protuberans. Genes Chromosomes Cancer (1996) 0.84

Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL). Eur J Cancer (2012) 0.83

Cytogenetic characterization of congenital or infantile fibrosarcoma. Eur J Pediatr (1991) 0.82

Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group. J Clin Oncol (1997) 0.81

5q- syndrome in a child. Cancer Genet Cytogenet (1995) 0.81

Biallelic alterations of both ETV6 and CDKN1B genes in a t(12;21) childhood acute lymphoblastic leukemia case. Cancer Res (1996) 0.79

Measurement of serum free thyroxine by RIA in various clinical states. J Nucl Med (1980) 0.78

Disease- and treatment-related elevation of the neurodegenerative marker tau in children with hematological malignancies. Leukemia (2000) 0.78

Abundant expression of cytokeratin 7 in fibrolamellar carcinoma of the liver. Histopathology (1990) 0.78

Loss of the Y-chromosome in a malignant Sertoli tumor. Cancer Genet Cytogenet (1993) 0.78

Mesenchymal hamartoma: radiological differentiation from other possible liver tumors in childhood. J Belge Radiol (1996) 0.77

Embryonal rhabdomyosarcoma with only numerical chromosome changes. Case report and review of the literature. Cancer Genet Cytogenet (1999) 0.77

A variant (2;13) translocation in rhabdomyosarcoma. Cancer Genet Cytogenet (1991) 0.77

Renal cell carcinoma in a child. Cancer Genet Cytogenet (1991) 0.76

Langerhans cell histiocytosis of the cervical spine: case report of an unusual location. Eur Radiol (1998) 0.76

Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents. Nephron (1987) 0.75

Aseptic meningitis associated with high dose intravenous immunoglobulin therapy. J Neurol Neurosurg Psychiatry (1992) 0.75

Cutaneous toxicity following administration of dactinomycin. Med Pediatr Oncol (1998) 0.75

Direct solid-phase 125I radioimmunoassay of serum cortisol. Clin Chem (1978) 0.75

Successful treatment of recurrent thrombotic thrombocytopenic purpura with plasmapheresis and vincristine. Eur J Pediatr (1994) 0.75

AIDS in two African infants born in Belgium. Acta Paediatr Scand (1987) 0.75

Mitoxantrone and high dose Ara-C for the treatment of ANLL in childhood: a pilot study of the EORTC CLCG (EORTC 58 872). Leukemia (1992) 0.75

Non-endemic Burkitt's lymphoma in a patient with Bloom's syndrome. Leuk Lymphoma (1993) 0.75

[Transient erythroblastopenia in 4 children]. Ned Tijdschr Geneeskd (1995) 0.75

Hemoglobin I High Wycombe in an Australian family. Hemoglobin (1987) 0.75

Bronchial artery to bronchial vein fistula secondary to lung nodule resection. Arch Dis Child (2005) 0.75

Being the 'med reg': an exploration of junior doctors' perceptions of the medical registrar role. J R Coll Physicians Edinb (2017) 0.75

Helping patients manage asthma. Am J Health Syst Pharm (1995) 0.75

Scottish nurse education: a touch of Celtic class. Nurs Mirror (1982) 0.75

Juvenile fibrosarcoma of the temporal bone. Med Pediatr Oncol (1996) 0.75

[Urinary tract infections in patients with incontinence problems]. Gynakol Geburtshilfliche Rundsch (1992) 0.75

[Prognostic value of peripartal thrombopenia]. Gynakol Rundsch (1991) 0.75

Brief report. Sudden death following removal of pericardial fluid in a child presenting with mediastinal lymphoma. Med Pediatr Oncol (1998) 0.75